Our findings mirror those seen in other malignancies, e.g. FOXA1 upregulation confering a good prognosis on cancers with high expression [37, 38] and is a representative marker of luminal-type cancers [39], and are compatible with DeGraff et al. given recent evidence of a dual role for up and down regulation of FOXA1 in cancer [40, 41]. This evidence concerns the gene FOXA1 and cancer.